Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate. [electronic resource]
- The Journal of urology Jul 2020
- 71-78 p. digital
Publication Type: Journal Article
1527-3792
10.1097/JU.0000000000000803 doi
Abiraterone Acetate--therapeutic use Antineoplastic Agents--therapeutic use Biomarkers, Tumor--blood Case-Control Studies Drug Resistance, Neoplasm--genetics Follow-Up Studies Humans Male Middle Aged Multivariate Analysis Progression-Free Survival Prospective Studies Prostatic Neoplasms, Castration-Resistant--blood Protein Isoforms--blood RNA--blood Receptors, Androgen--blood